GAMMA Investing’s MEDIROM Healthcare Technologies MRM Stock Holding History

GAMMA Investing’s Portfolio MRM Stock Details MRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.91K	Sell	3,798 -2,611	-41%	-$2.93K	﹤0.01%	3576
2026 Q1	$7.18K	Sell	6,409 -4,146	-39%	-$6.01K	﹤0.01%	3223
2025 Q4	$20.5K	Buy	10,555 +5,941	+129%	+$12.7K	﹤0.01%	2605
2025 Q3	$9.78K	Buy	4,614 +4,510	+4,337%	+$7.57K	﹤0.01%	2886
2025 Q2	$148	Buy	+104	New	+$115	﹤0.01%	3738
2025 Q1	–	Sell	-4,917	Closed	-$5.07K	–	3853
2024 Q4	$5.07K	Buy	+4,917	New	+$12.2K	﹤0.01%	2916

GAMMA Investing's MRM Position: Q2 2026 in Review

GAMMA Investing reduced its MEDIROM Healthcare Technologies (MRM) stake by 41% in Q2 2026, selling an estimated $2.93K and leaving 3,798 shares worth $3.91K. The position accounts for ﹤0.01% of the portfolio, ranked #3576.

GAMMA Investing first reported a position in MRM in Q4 2024 and has held it in 6 quarters since. The position peaked at $20.5K in Q4 2025. 1 fund tracked by Wall St. Rank holds MRM as of Q2 2026.

GAMMA Investing held 3,798 shares of MEDIROM Healthcare Technologies worth $3.91K as of Q2 2026.
GAMMA Investing sold 2,611 MEDIROM Healthcare Technologies shares in Q2 2026, an estimated $2.93K.
MEDIROM Healthcare Technologies made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3576 holding.
GAMMA Investing first reported a position in MEDIROM Healthcare Technologies in Q4 2024 and has held it in 6 quarters since.
GAMMA Investing's MEDIROM Healthcare Technologies position peaked at $20.5K in Q4 2025.
1 fund tracked by Wall St. Rank held MEDIROM Healthcare Technologies as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.